The Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH‘s 2021 Integrated Company Report highlights the international training program to enhance vaccine pharmacovigilance capacity in low and middle-income countries developed last year as a joint effort between P95 and GIZ. Through this initiative, our company contributed its knowledge and expertise on pharmacovigilance and vaccine safety and effectiveness studies, while GIZ provided support to roll out of the training through an international network, which included health agencies and experts from Ecuador, Ghana and Morocco.
You can find more on this initiative, featuring our team lead Zuleika Aponte (she/her/ella/elle), here: https://reporting.giz.de/2021/our-work-around-the-world/global-health/greater-vaccination-safety
P95 Welcomes Laurence De Moerlooze as Chief Medical Officer to Oversee Clinical and Epidemiology Operations
P95 BV, an Ampersand Capital Partners portfolio company, is proud to announce the appointment of Laurence De Moerlooze as Chief Medical Officer (CMO).
0 Comments